Market cap
$580 Mln
Revenue (TTM)
$77 Mln
P/E Ratio
--
P/B Ratio
9.8
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 8.89 | 31.80 | 22.01 | 14.86 | 3.59 |
| EBIT | -22.49 | -24.71 | -71.66 | -7.33 | -5.30 |
| Net Profit | 16.54 | 8.19 | -61.41 | -45.07 | -11.59 |
| EPS | 16.54 | 32.82 | -13.64 | 6.95 | 9.26 |
| Book Value | -- | -- | -61.05 | 101.96 | -25.93 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Dec-22 | Dec-21 | Dec-20 |
| EBIT-Margin
| -34.75 | -45.98 | -36.20 | -30.48 | -37.56 |
| Net Margin
| -47.38 | -56.37 | -- | -39.10 | -55.66 |
| Return on equity
| -222.37 | -192.13 | -84.92 | -72.61 | -509.60 |
| Return on Capital
| -34.65 | -44.88 | -38.97 | -27.51 | -37.47 |
| Return on Assets
| -28.78 | -34.61 | -32.96 | -23.62 | -29.75 |
| Debt to Equity (x)
| -- | -- | 1.75 | 0.87 | 8.58 |
Profitability
ROCE
-38.97
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Apollo Endosurgery (APEN)
|
-38.97
|
-27.51
|
-37.47
|
-51.72
|
-68.72
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-84.92
--
Profit after tax / Average Net worth * 100
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Apollo Endosurgery (APEN)
|
-84.92
|
-72.61
|
-509.60
|
-177.25
|
-116.29
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROA
-32.96
--
Profit after tax / Average Total assets * 100
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Apollo Endosurgery (APEN)
|
-32.96
|
-23.62
|
-29.75
|
-36.81
|
-49.90
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Margin
-36.20
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Apollo Endosurgery (APEN)
|
-36.20
|
-30.48
|
-37.56
|
-57.43
|
-68.25
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Margin
-51.84
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Apollo Endosurgery (APEN)
|
-51.84
|
-39.10
|
-55.66
|
-53.66
|
-77.06
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
0.22
--
Year on year growth in net sales
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Apollo Endosurgery (APEN)
|
0.22
|
0.50
|
-0.17
|
-0.17
|
-0.05
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Growth
-44.91
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Apollo Endosurgery (APEN)
|
-44.91
|
-21.56
|
45.77
|
29.88
|
-84.76
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
-61.41
--
Year on year growth in profit after tax
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Apollo Endosurgery (APEN)
|
-61.41
|
-9.16
|
17.57
|
40.09
|
-67.77
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EPS Growth
-0.18
--
Year on year growth in earnings per share
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Apollo Endosurgery (APEN)
|
-0.18
|
0.16
|
0.21
|
0.46
|
-0.17
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
1.75
--
Total debt / Net worth
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Apollo Endosurgery (APEN)
|
1.75
|
0.87
|
8.58
|
25.41
|
0.73
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.62
--
(Short term borrowings / Net worth)
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Apollo Endosurgery (APEN)
|
0.62
|
0.01
|
0.19
|
16.67
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.35
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Apollo Endosurgery (APEN)
|
2.35
|
7.92
|
5.02
|
0.97
|
1.97
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Quick Ratio
1.89
--
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Apollo Endosurgery (APEN)
|
1.89
|
7.09
|
4.13
|
0.80
|
1.56
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Interest Coverage
-5.96
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Apollo Endosurgery (APEN)
|
-5.96
|
-2.31
|
-3.01
|
-7.19
|
-10.22
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
19.51
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Apollo Endosurgery (APEN)
|
19.51
|
16.00
|
19.54
|
18.20
|
18.72
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Asset Turnover
0.64
--
Sales / Average Total Assets
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Apollo Endosurgery (APEN)
|
0.64
|
0.60
|
0.55
|
0.68
|
0.66
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Receivable days
59.57
--
Average Debtors / Sales * 365
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Apollo Endosurgery (APEN)
|
59.57
|
53.05
|
75.79
|
74.27
|
69.38
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
160.26
--
Average Inventory / Sales * 365
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Apollo Endosurgery (APEN)
|
160.26
|
145.11
|
176.77
|
137.10
|
160.28
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
63.67
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Apollo Endosurgery (APEN)
|
63.67
|
53.81
|
125.19
|
183.76
|
221.97
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
156.16
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Apollo Endosurgery (APEN)
|
156.16
|
144.35
|
127.37
|
27.61
|
7.69
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
-10.26
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Apollo Endosurgery (APEN)
|
-10.26
|
-10.25
|
-3.46
|
-2.29
|
-1.51
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
12.54
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Apollo Endosurgery (APEN)
|
12.54
|
4.13
|
11.58
|
29.53
|
2.39
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-14.59
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Apollo Endosurgery (APEN)
|
-14.59
|
-12.56
|
-7.40
|
-3.26
|
-2.05
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|